{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:35Z","timestamp":1787020115304,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"WesternU intramural startup fund","award":["1395"],"award-info":[{"award-number":["1395"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The head-twitch response (HTR) in mice is considered a behavioral model for hallucinogens and serotonin 5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      receptor function, as well as Tourette syndrome in humans. It is mediated by 5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      receptor agonists such as (\u2009\u00b1)\u2212\u00a02,5-dimethoxy-4-iodoamphetamine (DOI) in the prefrontal cortex (PFC). The 5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      antagonist EMD 281014, can prevent both DOI-induced HTR during ageing and\n                      <jats:italic>c-fos<\/jats:italic>\n                      expression in different regions of PFC. Moreover, the nonselective monoamine releaser methamphetamine (MA) suppressed DOI-induced HTR through ageing via concomitant activation of inhibitory 5-HT\n                      <jats:sub>1A<\/jats:sub>\n                      receptors, but enhanced DOI-evoked\n                      <jats:italic>c-fos<\/jats:italic>\n                      expression.\n                      <jats:italic>d<\/jats:italic>\n                      -Fenfluramine is a selective 5-HT releaser and induces HTR in mice, whereas MA does not. Currently, we investigated whether EMD 281014 or MA would alter: (1)\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-induced HTR frequency in 20-, 30- and 60-day old mice, (2)\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-evoked c-\n                      <jats:italic>fos<\/jats:italic>\n                      expression in PFC, and (3) whether blockade of inhibitory serotonergic 5-HT\n                      <jats:sub>1A<\/jats:sub>\n                      - or adrenergic \u0251\n                      <jats:sub>2<\/jats:sub>\n                      -receptors would prevent suppressive effect of MA on\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-induced HTR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      EMD 281014 (0.001\u20130.05\u00a0mg\/kg) or MA (0.1\u20135\u00a0mg\/kg) blocked\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-induced HTR dose-dependently during ageing. The 5-HT\n                      <jats:sub>1A<\/jats:sub>\n                      antagonist WAY 100635 countered the inhibitory effect of MA on\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-induced HTR in 30-day old mice, whereas the adrenergic \u0251\n                      <jats:sub>2<\/jats:sub>\n                      antagonist RS 79948 reversed MA\u2019s inhibitory effect in both 20- and 30- day old mice.\n                      <jats:italic>d<\/jats:italic>\n                      -Fenfluramine significantly increased c-\n                      <jats:italic>fos<\/jats:italic>\n                      expressions in PFC regions. MA (1\u00a0mg\/kg) pretreatment significantly increased\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-evoked c-\n                      <jats:italic>fos<\/jats:italic>\n                      expression in different regions of PFC. EMD 281014 (0.05\u00a0mg\/kg) failed to prevent\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-induced c-\n                      <jats:italic>fos<\/jats:italic>\n                      expression, but significantly increased it in one PFC region (PrL at \u2212\u00a02.68\u00a0mm).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      EMD 281014 suppressed\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-induced HTR but failed to prevent\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-evoked c-\n                      <jats:italic>fos<\/jats:italic>\n                      expression which suggest involvement of additional serotonergic receptors in the mediation of evoked c-\n                      <jats:italic>fos<\/jats:italic>\n                      . The suppressive effect of MA on\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-evoked HTR is due to well-recognized functional interactions between stimulatory 5-HT\n                      <jats:sub>2A<\/jats:sub>\n                      - and the inhibitory 5-HT\n                      <jats:sub>1A<\/jats:sub>\n                      - and \u0251\n                      <jats:sub>2<\/jats:sub>\n                      -receptors. MA-evoked increases in c-\n                      <jats:italic>fos<\/jats:italic>\n                      expression in PFC regions are due to the activation of diverse monoaminergic receptors through increased synaptic concentrations of 5-HT, NE and\/or DA, which may also account for the additive effect of MA on\n                      <jats:italic>d<\/jats:italic>\n                      -fenfluramine-evoked changes in c-\n                      <jats:italic>fos<\/jats:italic>\n                      expression. Our findings suggest potential drug receptor functional interaction during development when used in combination.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12868-022-00766-0","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T08:03:25Z","timestamp":1673424205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of low-doses of methamphetamine on d-fenfluramine-induced head-twitch response (HTR) in mice during ageing and c-fos expression in the prefrontal cortex"],"prefix":"10.1186","volume":"24","author":[{"given":"Yina","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Chebolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stone","family":"Skegrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissar A.","family":"Darmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/dta.1333","volume":"4","author":"CE Canal","year":"2012","unstructured":"Canal CE, Morgan D. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal. 2012;4:556\u201376.","journal-title":"Drug Test Anal"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","volume":"167","author":"AL Halberstadt","year":"2020","unstructured":"Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology. 2020;167:107933.","journal-title":"Neuropharmacology"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0278-5846(01)00194-4","volume":"25","author":"Y Tizabi","year":"2001","unstructured":"Tizabi Y, Russell LT, Johnson M, Darmani NA. Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome. Prog Neuropsychopharmacol Biol Psychiatr. 2001;25:1445\u201357.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s11011-017-0084-3","volume":"32","author":"L Hongyan","year":"2017","unstructured":"Hongyan L, Zhenyang S, Chunyan W, Qingqing P. Lipopolysaccharide aggravated DOI-induced Tourette syndrome: elaboration for recurrence of Tourette syndrome. Metab Brain Dis. 2017;32:1929\u201334.","journal-title":"Metab Brain Dis"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejphar.2004.02.018","volume":"488","author":"NA Darmani","year":"2004","unstructured":"Darmani NA, Johnson JC. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Eur J Pharmacol. 2004;488:201\u201312.","journal-title":"Eur J Pharmacol"},{"key":"766_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0091-3057(96)00108-6","volume":"55","author":"NA Darmani","year":"1996","unstructured":"Darmani NA, Reeves SL. The stimulatory and inhibitory components of cocaine\u2019s actions on the 5-HTP-induced 5-HT2A receptor response. Pharmacol Biochem Behav. 1996;55:387\u201396.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","volume":"36","author":"NA Darmani","year":"1990","unstructured":"Darmani NA, Martin BR, Pandey U, Glennon RA. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav. 1990;36:901\u20136.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0091-3057(97)00548-0","volume":"60","author":"NA Darmani","year":"1998","unstructured":"Darmani NA. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice. Pharmacol Biochem Behav. 1998;60:83\u201390.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 2007;53:439\u201352.","journal-title":"Neuron"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0014-2999(90)94066-7","volume":"186","author":"NA Darmani","year":"1990","unstructured":"Darmani NA, Martin BR, Glennon RA. Withdrawal from chronic treatment with (+\/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice. Eur J Pharmacol. 1990;186:115\u20138.","journal-title":"Eur J Pharmacol"},{"key":"766_CR11","first-page":"101","volume":"273","author":"R Schreiber","year":"1995","unstructured":"Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther. 1995;273:101\u201312.","journal-title":"J Pharmacol Exp Ther"},{"key":"766_CR12","first-page":"699","volume":"282","author":"DL Willins","year":"1997","unstructured":"Willins DL, Meltzer HY. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther. 1997;282:699\u2013706.","journal-title":"J Pharmacol Exp Ther"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12868-021-00686-5","volume":"23","author":"Y Sun","year":"2022","unstructured":"Sun Y, Chebolu S, Henry D, Lankireddy S, Darmani NA. An ontogenic study of receptor mechanisms by which acute administration of low-doses of methamphetamine suppresses DOI-induced 5-HT2A-receptor mediated head-twitch response in mice. BMC Neurosci. 2022;23:2.","journal-title":"BMC Neurosci"},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/sj.ijo.0800795","volume":"23","author":"AJ Scheen","year":"1999","unstructured":"Scheen AJ, Lef\u00e9bvre PJ. Pharmacological treatment of obesity: present status. Int J Obes Relat Metab Disord. 1999;23:47\u201353.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"766_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01209-8","author":"B Wijnen","year":"2022","unstructured":"Wijnen B, Witlox W, Wolff R, Fayter D, Ramaekers B, Otten T, et al. Fenfluramine for treating dravet syndrome: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics. 2022. https:\/\/doi.org\/10.1007\/s40273-022-01209-8.","journal-title":"Pharmacoeconomics"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0091-3057(01)00669-4","volume":"71","author":"RB Rothman","year":"2002","unstructured":"Rothman RB, Baumann MH. Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav. 2002;71:825\u201336.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.bjp.0702067","volume":"125","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Cheetham SC, Prow MR, Martin KF, Buckett WR. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents. Br J Pharmacol. 1998;125:301\u20138.","journal-title":"Br J Pharmacol"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0006-8993(89)91365-6","volume":"504","author":"B Laferrere","year":"1989","unstructured":"Laferrere B, Wurtman RJ. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats. Brain Res. 1989;504:258\u201363.","journal-title":"Brain Res"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0006-8993(92)91249-E","volume":"585","author":"KE Sabol","year":"1992","unstructured":"Sabol KE, Richards JB, Seiden LS. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 1992;585:421\u20134.","journal-title":"Brain Res"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1523\/JNEUROSCI.1665-10.2010","volume":"30","author":"CL Schmid","year":"2010","unstructured":"Schmid CL, Bohn LM. Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ss-arrestin2\/Src\/Akt signaling complex in vivo. J Neurosci. 2010;30:13513\u201324.","journal-title":"J Neurosci"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbrc.2022.01.113","volume":"598","author":"X Liu","year":"2022","unstructured":"Liu X, Zhu H, Gao H, Tian X, Tan B, Su R. Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice. Biochem Biophys Res Commun. 2022;598:20\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/S0024-3205(97)01012-6","volume":"61","author":"NA Darmani","year":"1997","unstructured":"Darmani NA. Deficits in D-fenfluramine-sensitive pool of brain 5-HT following withdrawal from chronic cocaine exposure. Life Sci. 1997;61:2575\u201382.","journal-title":"Life Sci"},{"key":"766_CR23","first-page":"121","volume":"84","author":"DM Kuhn","year":"1985","unstructured":"Kuhn DM, Wolf WA, Youdim MB. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats. Br J Pharmacol. 1985;84:121\u20139.","journal-title":"Br J Pharmacol"},{"key":"766_CR24","first-page":"643","volume":"273","author":"M Raiteri","year":"1995","unstructured":"Raiteri M, Bonanno G, Vallebuona F. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J Pharmacol Exp Ther. 1995;273:643\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.biopsych.2009.02.021","volume":"66","author":"MS Gold","year":"2009","unstructured":"Gold MS, Kobeissy FH, Wang KK, Merlo LJ, Bruijnzeel AW, Krasnova IN, et al. Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates. Biol Psychiatr. 2009;66:118\u201327.","journal-title":"Biol Psychiatr"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4103\/1673-5374.268895","volume":"15","author":"G Costa","year":"2020","unstructured":"Costa G, De Luca MA, Piras G, Marongiu J, Fattore L, Simola N. Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies. Neural Regen Res. 2020;15:802\u201316.","journal-title":"Neural Regen Res"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005;75:406\u201333.","journal-title":"Prog Neurobiol"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104:1085\u201399.","journal-title":"Addiction"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2014.08.003","volume":"143","author":"KE Courtney","year":"2014","unstructured":"Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11\u201321.","journal-title":"Drug Alcohol Depend"},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1124\/jpet.106.115402","volume":"321","author":"EA Reese","year":"2007","unstructured":"Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK. Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J Pharmacol Exp Ther. 2007;321:178\u201386.","journal-title":"J Pharmacol Exp Ther"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","volume":"49","author":"EC Nguyen","year":"2005","unstructured":"Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology. 2005;49:638\u201345.","journal-title":"Neuropharmacology"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0006-8993(00)03244-3","volume":"892","author":"KE Sabol","year":"2001","unstructured":"Sabol KE, Roach JT, Broom SL, Ferreira C, Preau MM. Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res. 2001;892:122\u20139.","journal-title":"Brain Res"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1046\/j.1471-4159.2001.00549.x","volume":"79","author":"MR Gluck","year":"2001","unstructured":"Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem. 2001;79:152\u201360.","journal-title":"J Neurochem"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/sj.npp.1300575","volume":"30","author":"LJ Madden","year":"2005","unstructured":"Madden LJ, Flynn CT, Zandonatti MA, May M, Parsons LH, Katner SN, et al. Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology. 2005;30:350\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"766_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuro.2019.12.006","volume":"77","author":"S Sabrini","year":"2020","unstructured":"Sabrini S, Russell B, Wang G, Lin J, Kirk I, Curley L. Methamphetamine induces neuronal death: Evidence from rodent studies. Neurotoxicology. 2020;77:20\u20138.","journal-title":"Neurotoxicology"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1017\/S1461145714000455","volume":"17","author":"HY Chiu","year":"2014","unstructured":"Chiu HY, Chan MH, Lee MY, Chen ST, Zhan ZY, Chen HH. Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice. Int J Neuropsychopharmacol. 2014;17:1647\u201358.","journal-title":"Int J Neuropsychopharmacol"},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1038\/tp.2015.57","volume":"5","author":"KA Rahn","year":"2015","unstructured":"Rahn KA, Cao Y-J, Hendrix CW, Kaplin AI. The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression. Transl Psychiatry. 2015;5:e563.","journal-title":"Transl Psychiatry"},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jphs.2021.01.005","volume":"145","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao L, Li AY. Gastrodin - A potential drug used for the treatment of Tourette syndrome. J Pharmacol Sci. 2021;145:289\u201395.","journal-title":"J Pharmacol Sci"},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pjnns.2017.10.015","volume":"52","author":"P Janik","year":"2017","unstructured":"Janik P, Szejko N. Aripiprazole in treatment of Gilles de la Tourette syndrome\u2014new therapeutic option. Neurol Neurochir Pol. 2017;52:84\u20137.","journal-title":"Neurol Neurochir Pol"},{"key":"766_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0091-3057(91)90290-I","volume":"38","author":"NA Darmani","year":"1991","unstructured":"Darmani NA, Martin BR, Pandey U, Glennon RA. Inhibition of 5-HT2 receptor-mediated head-twitch response by cocaine via indirect stimulation of adrenergic alpha 2 and serotonergic 5-HT1A receptors. Pharmacol Biochem Behav. 1991;38:353\u20137.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR41","unstructured":"World Drug Report. Stimulants. The United Nations Office on Drugs and Crime (UNODC). Sales No. E.19.XI.8, June. United Nations publication; 2019."},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0031-9384(96)00323-X","volume":"60","author":"NA Darmani","year":"1996","unstructured":"Darmani NA, Shaddy J, Gerdes CF. Differential ontogenesis of three DOI-induced behaviors in mice. Physiol Behav. 1996;60:1495\u2013500.","journal-title":"Physiol Behav"},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejphar.2004.06.065","volume":"497","author":"V Fagerholm","year":"2004","unstructured":"Fagerholm V, Philipp M, Hein L, Scheinin M. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice. Eur J Pharmacol. 2004;497:301\u20139.","journal-title":"Eur J Pharmacol"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejphar.2004.09.017","volume":"504","author":"R Adamec","year":"2004","unstructured":"Adamec R, Creamer K, Bartoszyk GD, Burton P. Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats. Eur J Pharmacol. 2004;504:79\u201396.","journal-title":"Eur J Pharmacol"},{"key":"766_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/0091-3057(94)00340-8","volume":"50","author":"NA Darmani","year":"1995","unstructured":"Darmani NA, Gerdes CF. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacol Biochem Behav. 1995;50:545\u201350.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR46","unstructured":"Paxinos G and Franklin KBJ. The mouse brain in stereotaxic coordinates, deluxe ed. of the Atlas, 2nd ed., San Diego: Academic Press; 2001."},{"key":"766_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","volume":"293","author":"M Dragunow","year":"1989","unstructured":"Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods. 1989;293:261\u20135.","journal-title":"J Neurosci Methods"},{"key":"766_CR48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/328632a0","volume":"3286131","author":"SP Hunt","year":"1987","unstructured":"Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 1987;3286131:632\u20134.","journal-title":"Nature"},{"key":"766_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0165-3806(91)90236-C","volume":"58","author":"BL Roth","year":"1991","unstructured":"Roth BL, Hamblin MW, Ciaranello RD. Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels. Brain Res Dev Brain Res. 1991;58:51\u20138.","journal-title":"Brain Res Dev Brain Res"},{"key":"766_CR50","first-page":"1051","volume":"244","author":"Y Claustre","year":"1988","unstructured":"Claustre Y, Rouquier L, Scatton B. Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat. J Pharmacol Exp Ther. 1988;244:1051\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"766_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0006-8993(84)91397-0","volume":"311","author":"JO Marcusson","year":"1984","unstructured":"Marcusson JO, Morgan DG, Winblad B, Finch CE. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res. 1984;311:51\u20136.","journal-title":"Brain Res"},{"key":"766_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(93)90286-V","volume":"620","author":"B Arranz","year":"1993","unstructured":"Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J. Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res. 1993;620:163\u20136.","journal-title":"Brain Res"},{"key":"766_CR53","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/0024-3205(94)00320-3","volume":"55","author":"T Nabeshima","year":"1994","unstructured":"Nabeshima T, Yamada K, Hayashi T, Hasegawa T, Ishihara S, Kameyama T, et al. Changes in muscarinic cholinergic, PCP, GABAA, D1, and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats. Life Sci. 1994;55:1585\u201393.","journal-title":"Life Sci"},{"key":"766_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0024-3205(91)90579-Z","volume":"49","author":"R Arevalo","year":"1991","unstructured":"Arevalo R, Afonso D, Castro R, Rodriguez M. Fetal brain serotonin synthesis and catabolism is under control by mother intake of tryptophan. Life Sci. 1991;49:53\u201366.","journal-title":"Life Sci"},{"key":"766_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/01485019708987905","volume":"39","author":"A Valencia-Sanchez","year":"1997","unstructured":"Valencia-Sanchez A, Esparza-Avalos NS, Cruz ML, Ortega-Corona BG. Amine neurotransmitter levels in male and female rats through developmental periods. Arch Androl. 1997;39:79\u201383.","journal-title":"Arch Androl"},{"key":"766_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0091-3057(03)00065-0","volume":"75","author":"A Birthelmer","year":"2003","unstructured":"Birthelmer A, Lazaris A, Schweizer T, Jackisch R, Cassel JC. Presynaptic regulation of neurotransmitter release in the cortex of aged rats with differential memory impairments. Pharmacol Biochem Behav. 2003;75:147\u201362.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0197-4580(89)80016-8","volume":"10","author":"RM Murphy","year":"1989","unstructured":"Murphy RM, Zemlan FP. Functional change in the 5-HT presynaptic receptor in spinal cord of aged rats. Neurobiol Aging. 1989;10:95\u20137.","journal-title":"Neurobiol Aging"},{"key":"766_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0014-2999(89)90178-7","volume":"161","author":"J Arnt","year":"1989","unstructured":"Arnt J, Hyttel J. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Eur J Pharmacol. 1989;161:45\u201351.","journal-title":"Eur J Pharmacol"},{"key":"766_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejmech.2016.03.073","volume":"116","author":"A Bielenica","year":"2016","unstructured":"Bielenica A, Kedzierska E, Kolinski M, Kmiecik S, Kolinski A, Fiorino F, et al. 5-HT2 receptor affinity, docking studies and pharmacological evaluation of a series of 1,3-disubstituted thiourea derivatives. Eur J Med Chem. 2016;116:173\u201386.","journal-title":"Eur J Med Chem"},{"key":"766_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/FBP.0b013e32834aff98","volume":"22","author":"K McFarland","year":"2011","unstructured":"McFarland K, Price DL, Bonhaus DW. Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson\u2019s disease. Behav Pharmacol. 2011;22:681\u201392.","journal-title":"Behav Pharmacol"},{"key":"766_CR61","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A. Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol. 2013;85:1803\u201315.","journal-title":"Biochem Pharmacol"},{"key":"766_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0165-0270(91)90031-T","volume":"37","author":"J Drago","year":"1991","unstructured":"Drago J, Murphy M, Bailey KA, Bartlett PF. A method for the isolation of purified murine neuroepithelial cells from the developing mouse brain. J Neurosci Methods. 1991;37:251\u20136.","journal-title":"J Neurosci Methods"},{"key":"766_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(85)90857-1","volume":"346","author":"A Pazos","year":"1985","unstructured":"Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 1985;346:231\u201349.","journal-title":"Brain Res"},{"key":"766_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A","volume":"27","author":"DL Willins","year":"1997","unstructured":"Willins DL, Deutch AY, Roth BL. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 1997;27:79\u201382.","journal-title":"Synapse"},{"key":"766_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.euroneuro.2021.05.012","volume":"52","author":"I Brocos-Mosquera","year":"2021","unstructured":"Brocos-Mosquera I, Gabilondo AM, Diez-Alarcia R, Muguruza C, Erdozain AM, Meana JJ, et al. alpha2A- and alpha2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects. Eur Neuropsychopharmacol. 2021;52:3\u201311.","journal-title":"Eur Neuropsychopharmacol"},{"key":"766_CR66","doi-asserted-by":"publisher","first-page":"107731","DOI":"10.1016\/j.neuropharm.2019.107731","volume":"158","author":"I Horrillo","year":"2019","unstructured":"Horrillo I, Ortega JE, Diez-Alarcia R, Uriguen L, Meana JJ. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on alpha2-adrenoceptors in the rat frontal cortex but not locus coeruleus. Neuropharmacology. 2019;158:107731.","journal-title":"Neuropharmacology"},{"key":"766_CR67","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","volume":"14","author":"N Santana","year":"2004","unstructured":"Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of serotonin1A and serotonin 2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex. 2004;14:1100\u20139.","journal-title":"Cereb Cortex"},{"key":"766_CR68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2010.04.046","volume":"169","author":"A Marzo","year":"2010","unstructured":"Marzo A, Bai J, Caboche J, Vanhoutte P, Otani S. Cellular mechanisms of long-term depression induced by noradrenaline in rat prefrontal neurons. Neuroscience. 2010;169:74\u201386.","journal-title":"Neuroscience"},{"key":"766_CR69","first-page":"36","volume":"4","author":"ET Weber","year":"2010","unstructured":"Weber ET, Andrade R. Htr2a gene and 5-HT(2A) receptor expression in the cerebral cortex studied using genetically modified mice. Front Neurosci. 2010;4:36.","journal-title":"Front Neurosci"},{"key":"766_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/cercor\/bhg128","volume":"14","author":"M Amargos-Bosch","year":"2004","unstructured":"Amargos-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, et al. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex. 2004;14:281\u201399.","journal-title":"Cereb Cortex"},{"key":"766_CR71","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0306-4522(91)90128-B","volume":"40","author":"R Araneda","year":"1991","unstructured":"Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 1991;40:399\u2013412.","journal-title":"Neuroscience"},{"key":"766_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/syn.890170306","volume":"17","author":"CR Ashby Jr","year":"1994","unstructured":"Ashby CR Jr, Edwards E, Wang RY. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse. 1994;17:173\u201381.","journal-title":"Synapse"},{"key":"766_CR73","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s007020050085","volume":"105","author":"NA Darmani","year":"1998","unstructured":"Darmani NA. The silent and selective 5-HT1A antagonist, WAY 100635, produces via an indirect mechanism, a 5-HT2A receptor-mediated behaviour in mice during the day but not at night. Short communication. J Neural Transm. 1998;105:635\u201343.","journal-title":"J Neural Transm"},{"key":"766_CR74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0376-8716(00)00232-5","volume":"64","author":"M Haney","year":"2001","unstructured":"Haney M, Ward AS, Gerra G, Foltin RW. Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans. Drug Alcohol Depend. 2001;64:63\u201373.","journal-title":"Drug Alcohol Depend"},{"key":"766_CR75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0014-2999(95)00280-X","volume":"282","author":"MH Baumann","year":"1995","unstructured":"Baumann MH, Becketts KM, Rothman RB. Evidence for alterations in presynaptic serotonergic function during withdrawal from chronic cocaine in rats. Eur J Pharmacol. 1995;282:87\u201393.","journal-title":"Eur J Pharmacol"},{"key":"766_CR76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0006-3223(99)00180-8","volume":"47","author":"G Gerra","year":"2000","unstructured":"Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, et al. Long-lasting effects of (+\/-)3,4-Methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biol Psychiatry. 2000;47:127\u201336.","journal-title":"Biol Psychiatry"},{"key":"766_CR77","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0028-3908(94)90063-9","volume":"33","author":"AD Levy","year":"1994","unstructured":"Levy AD, Li Q, Van de Kar LD. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT. Neuropharmacology. 1994;33:335\u201342.","journal-title":"Neuropharmacology"},{"key":"766_CR78","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/JCP.0000000000001595","volume":"42","author":"CM Price","year":"2022","unstructured":"Price CM, Feduccia AA, DeBonis K. Effects of selective serotonin reuptake inhibitor use on 3,4-methylenedioxymethamphetamine-assisted therapy for posttraumatic stress disorder: a review of the evidence, neurobiological plausibility, and clinical significance. J Clin Psychopharmacol. 2022;42:464\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"766_CR79","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0361-9230(93)90009-Z","volume":"31","author":"BH Li","year":"1993","unstructured":"Li BH, Rowland NE. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res Bull. 1993;31:43\u20138.","journal-title":"Brain Res Bull"},{"key":"766_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0006-8993(94)91881-3","volume":"640","author":"BH Li","year":"1994","unstructured":"Li BH, Spector AC, Rowland NE. Reversal of dexfenfluramine-induced anorexia and c-Fos\/c-Jun expression by lesion in the lateral parabrachial nucleus. Brain Res. 1994;640:255\u201367.","journal-title":"Brain Res"},{"key":"766_CR81","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.neuroscience.2009.04.023","volume":"161","author":"NB Gross","year":"2009","unstructured":"Gross NB, Marshall JF. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience. 2009;161:1114\u201325.","journal-title":"Neuroscience"},{"key":"766_CR82","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0169-328X(95)00284-Y","volume":"37","author":"C Rouillard","year":"1996","unstructured":"Rouillard C, Bovetto S, Gervais J, Richard D. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine. Brain Res Mol Brain Res. 1996;37:105\u201315.","journal-title":"Brain Res Mol Brain Res"},{"key":"766_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0006-8993(98)00082-1","volume":"791","author":"A Javed","year":"1998","unstructured":"Javed A, Van de Kar LD, Gray TS. The 5-HT1A and 5-HT2A\/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain. Brain Res. 1998;791:67\u201374.","journal-title":"Brain Res"},{"key":"766_CR84","doi-asserted-by":"publisher","first-page":"751913","DOI":"10.3389\/fnagi.2021.751913","volume":"13","author":"BC Shyu","year":"2021","unstructured":"Shyu BC, Gao ZY, Wu JJ, He ABH, Cheng CN, Huang ACW. Methamphetamine and modulation functionality of the prelimbic cortex for developing a possible treatment of alzheimer\u2019s disease in an animal model. Front Aging Neurosci. 2021;13:751913.","journal-title":"Front Aging Neurosci"},{"key":"766_CR85","doi-asserted-by":"publisher","first-page":"173089","DOI":"10.1016\/j.pbb.2020.173089","volume":"201","author":"ST Pittenger","year":"2021","unstructured":"Pittenger ST, Chou S, Murawski NJ, Barrett ST, Loh O, Duque JF, et al. Female rats display higher methamphetamine-primed reinstatement and c-Fos immunoreactivity than male rats. Pharmacol Biochem Behav. 2021;201:173089.","journal-title":"Pharmacol Biochem Behav"},{"key":"766_CR86","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1124\/jpet.103.049684","volume":"305","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Clark RD, Partilla JS, Baumann MH. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. J Pharmacol Exp Ther. 2003;305:1191\u20139.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-022-00766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-022-00766-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-022-00766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T09:06:49Z","timestamp":1673428009000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-022-00766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s12868-022-00766-0","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The article is based on previously published studies and is in line with the journal\u2019s ethical guidelines. The protocol (#20IACUC013) was approved by the Western University of Health Sciences Institutional Animal Care and Use Committee (IACUC). All experiments were conducted with strict adherence to the recommendations in the guide for the Care and Use of Laboratory Animals of the National Institute of Health (Department of Health and Human Services Publication, revised, 2011). All methods were carried out in accordance with the relevant guidelines and regulations and are reported in accordance with ARRIVE guidelines for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}